Statement of Deviaton & Variation as on September 30, 2025 from utilization of funds raised through IPO
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory has filed a quarterly compliance statement under SEBI Regulation 32 confirming no deviation or variation in the use of funds raised through its IPO. The company raised INR 578.30 Lakhs via public issue (allotment date July 30, 2024), earmarked for expansion of diagnostic centres, general corporate purposes, and IPO-related expenses. As of September 30, 2025, INR 428.30 Lakhs has been utilised, with zero deviation reported for the quarter. No monitoring agency was applicable, and there are no adverse comments from the audit committee or auditors.
This is a routine regulatory filing that confirms the company is deploying IPO proceeds as originally disclosed in its prospectus. For retail investors, this signals good governance and no concerns about misuse of funds, though it is neutral for short-term stock price movement.